ClinConnect ClinConnect Logo
Search / Trial NCT06875518

Comparative Study of Blood Loss in Total Laparoscopic Hysterectomy by Ligation the Uterine Arteries in Different Techniques.

Launched by MOSTAFA BAHAA · Mar 9, 2025

Trial Information

Current as of April 29, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying different techniques for reducing blood loss during a surgery called total laparoscopic hysterectomy (TLH), which is a minimally invasive way to remove the uterus. This surgery is commonly performed on women who have heavy menstrual bleeding (called menometrorrhagia) that hasn't improved with medical treatment, or other uterine issues like adenomyosis or fibroids. By comparing various methods of ligating (tying off) the uterine arteries, the researchers aim to find the safest and most effective approach.

To participate in this study, women aged 35 to 60 who are experiencing these gynecological problems may be eligible. However, certain conditions might prevent participation, such as serious health issues that make anesthesia risky or if a woman has cancer of the uterus. Those who join the trial can expect to undergo a laparoscopic surgery with the aim of reducing blood loss, and they will be closely monitored during and after the procedure. It's important to note that this study is currently recruiting participants, and it seeks to enhance the safety and effectiveness of hysterectomy procedures for women facing these health challenges.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged between 35-60 years Patients presented with menometrorrhagia unresponsive to medical treatment, and uterine pathology such as adenomyosis or multiple fibroids.
  • Exclusion Criteria:
  • Patients were excluded if they had: medical conditions preventing pneumo-peritoneum
  • Patients with medical conditions hindering proper ventilation during general anesthesia.
  • Patients diagnosed with endometrial carcinoma and patients with uterine size larger than 24 weeks were excluded.
  • Patients with excessive adhesions precluding access to the uterine arteries were not enrolled in the study.

About Mostafa Bahaa

Mostafa Bahaa is a dedicated clinical trial sponsor committed to advancing medical research and patient care through rigorous and ethical clinical studies. With a focus on innovative therapeutic solutions, the organization collaborates with leading researchers and healthcare institutions to ensure the highest standards of scientific integrity and regulatory compliance. Mostafa Bahaa prioritizes patient safety and data transparency, striving to contribute valuable insights that enhance treatment options and improve health outcomes across diverse medical fields.

Locations

Damietta, New Damietta, Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported